These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1238 related items for PubMed ID: 15207952
1. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A, VALUE trial group. Lancet; 2004 Jun 19; 363(9426):2022-31. PubMed ID: 15207952 [Abstract] [Full Text] [Related]
2. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D. Clin Ther; 2005 May 19; 27(5):578-87. PubMed ID: 15978306 [Abstract] [Full Text] [Related]
3. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial. Zanchetti A, Julius S, Kjeldsen S, McInnes GT, Hua T, Weber M, Laragh JH, Plat F, Battegay E, Calvo-Vargas C, Cieśliński A, Degaute JP, Holwerda NJ, Kobalava J, Pedersen OL, Rudyatmoko FP, Siamopoulos KC, Störset O. J Hypertens; 2006 Nov 19; 24(11):2163-8. PubMed ID: 17053536 [Abstract] [Full Text] [Related]
10. The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design. Mann J, Julius S. Blood Press; 1998 May 19; 7(3):176-83. PubMed ID: 9758088 [Abstract] [Full Text] [Related]
14. A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives. Weir MR, Ferdinand KC, Flack JM, Jamerson KA, Daley W, Zelenkofske S. Hypertension; 2005 Sep 19; 46(3):508-13. PubMed ID: 16116046 [Abstract] [Full Text] [Related]
15. Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. Ogihara T, Nakao K, Fukui T, Fukiyama K, Ueshima K, Oba K, Sato T, Saruta T, Candesartan Antihypertensive Survival Evaluation in Japan Trial Group. Hypertension; 2008 Feb 19; 51(2):393-8. PubMed ID: 18172059 [Abstract] [Full Text] [Related]
16. Valsartan Amlodipine Randomized Trial (VART): design, methods, and preliminary results. Nakayama K, Kuwabara Y, Daimon M, Shindo S, Fujita M, Narumi H, Mizuma H, Komuro I. Hypertens Res; 2008 Jan 19; 31(1):21-8. PubMed ID: 18360014 [Abstract] [Full Text] [Related]
17. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Weber MA, Julius S, Kjeldsen SE, Brunner HR, Ekman S, Hansson L, Hua T, Laragh JH, McInnes GT, Mitchell L, Plat F, Schork MA, Smith B, Zanchetti A. Lancet; 2004 Jun 19; 363(9426):2049-51. PubMed ID: 15207957 [Abstract] [Full Text] [Related]
19. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension. Frampton JE, Scott LJ. Am J Cardiovasc Drugs; 2009 Jun 19; 9(5):309-30. PubMed ID: 19791840 [Abstract] [Full Text] [Related]
20. Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination. Trenkwalder P, Schaetzl R, Borbas E, Handrock R, Klebs S. Blood Press Suppl; 2008 Dec 19; 2():13-21. PubMed ID: 19205092 [Abstract] [Full Text] [Related] Page: [Next] [New Search]